Observation Study on the Efficacy of Yiqi Gubiao Pill in the Treatment of Chronic Obstructive Pulmonary Disease Secondary to Active Pulmonary Tuberculosis

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

March 31, 2025

Conditions
Tuberculosis-related Obstructive Pulmonary Disease
Interventions
DRUG

Yiqi Gubiao pill

Take 10 pills orally each time, three times a day, after meals, for a continuous period of 12 weeks. Receiving basic treatment: standardized quadruple anti-tuberculosis therapy is administered, with Rifampicin, Isoniazid, Ethambutol, and Pyrazinamide used for the first 2 months, followed by Rifampicin and Isoniazid for the next 4 months.

DRUG

Yiqi Gubiao Pill placebo

The placebo's appearance and content color are similar to that of Yiqi Gubiao Pill, with the main ingredients being starch and caramel. Take 10 pills orally each time, three times a day, after meals, for a continuous period of 12 weeks. Receiving basic treatment: standardized quadruple anti-tuberculosis therapy is administered, with Rifampicin, Isoniazid, Ethambutol, and Pyrazinamide used for the first 2 months, followed by Rifampicin and Isoniazid for the next 4 months.

All Listed Sponsors
collaborator

Beijing University of Chinese Medicine

OTHER

lead

Fourth Affiliated Hospital of Xinjiang Medical University

OTHER

NCT06676800 - Observation Study on the Efficacy of Yiqi Gubiao Pill in the Treatment of Chronic Obstructive Pulmonary Disease Secondary to Active Pulmonary Tuberculosis | Biotech Hunter | Biotech Hunter